Staging Your Liver Health: Fibrosis and Testing

Because MASH is a silent disease, doctors need specialized ways to look “under the hood” to see how your liver is doing. The most important thing they are looking for is fibrosis, which is the medical term for scarring.

Fibrosis is the single most important predictor of long-term health in MASH ^[1][2]. While fat and inflammation (disease activity) can come and go, the amount of scarring determines how well the liver can function over time. Knowing your estimated “stage” of fibrosis helps your care team understand your risk and decide on the best management plan ^[3][4].

The Five Stages of Fibrosis

Doctors use a scale from F0 to F4 to describe how much scarring is present in the liver. Note that this scale describes fibrosis only, not fat, inflammation, or overall liver health:

• F0 (No Significant Fibrosis): No significant scarring is detected ^[5]. However, a person can still have substantial steatosis (fat), active MASH, or cardiovascular risk.
• F1 (Mild Fibrosis): There is a small amount of scarring, often located around the liver’s blood vessels ^[5][6].
• F2 (Moderate Fibrosis): Scarring has begun to spread and connect different areas of the liver ^[5].
• F3 (Severe or Bridging Fibrosis): The scarring is extensive and forms “bridges” across the liver tissue, though the liver can still function ^[5][2].
• F4 (Cirrhosis): This is advanced scarring that distorts the liver’s structure and can eventually lead to liver failure or other serious complications ^[5][2].

The Step-by-Step Path to Diagnosis

In the past, the only way to know your fibrosis stage was through a liver biopsy—using a needle to take a small piece of liver tissue for examination. While biopsy is still the “gold standard” for some diagnoses and for histologic confirmation, it is invasive, carries a small risk of complications, and can sometimes miss scarred areas ^[7][8].

Today, doctors prefer a “step-wise” approach using Non-Invasive Tests (NITs) that are safer and easier to repeat to estimate risk ^[4][9].

Step 1: The FIB-4 Blood Test

The first tool used is almost always the FIB-4 score. This isn’t a separate blood draw; it is a calculation your doctor makes using your age and standard lab results (AST, ALT, and platelet count) ^[10].

• Low Risk (Often Below 1.3): For most people under 65, a score below 1.3 suggests a low chance of advanced fibrosis ^[10]. (For those over 65, the “low risk” cutoff is often shifted to 2.0) ^[10].
• Intermediate Risk (1.3 to 2.67): This score is “indeterminate,” meaning more testing is needed to be sure ^[10].
• High Risk (Above 2.67): A score in this range suggests a higher likelihood of advanced fibrosis and usually prompts an immediate referral to a specialist ^[10][9].

Note that FIB-4 thresholds are context-dependent. They are age-dependent, less reliable in younger adults and older adults, and affected by acute illness and other causes of abnormal AST, ALT, or platelets; a score does not definitively diagnose advanced fibrosis.

Step 2: Measuring Stiffness with Imaging

If your FIB-4 is not clearly low-risk, the next step is often a test to measure liver stiffness. Because scarred tissue is stiffer than healthy tissue, measuring “bounce-back” or “vibrations” can estimate the amount of fibrosis ^[11].

• Transient Elastography (FibroScan): This is the most common imaging test. It uses a specialized ultrasound probe to send a “shear wave” through the liver ^[11].
  • Under 8 kPa: Generally suggests low risk ^[10].
  • Over 12 kPa: Generally suggests a high risk of advanced fibrosis ^[10].
    These values are approximate rule-out/rule-in thresholds that vary by device, probe, obesity, recent meals, inflammation, and local guidelines. They do not translate directly into a specific F stage.
• MRE (Magnetic Resonance Elastography): This is the most accurate imaging test for staging fibrosis ^[11]. It combines an MRI with sound waves to create a visual map of liver stiffness. It is often used if other tests are unclear or there are discordant results ^[12][11].

Other Blood-Based Tests

If your case is complex, your doctor might use the ELF (Enhanced Liver Fibrosis) score. This blood test looks for specific markers of scarring in your blood ^[13]. A score above 9.8 is typically used to identify patients who need more intensive specialist care ^[14].

Why Accuracy Matters

Staging isn’t just about giving the disease a number; it’s about predicting your future health. For example, people with F3 or F4 fibrosis have a much higher risk of liver-related events compared to those at F0 or F1 ^[3][15]. By using these non-invasive tools, your doctor can catch changes early and adjust your treatment to prevent the disease from moving to the next stage ^[16].